 Immunosuppressive Agents
"Immunosuppressive Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging.
| Descriptor ID |
D007166
|
| MeSH Number(s) |
D27.505.696.477.656
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Immunosuppressive Agents".
Below are MeSH descriptors whose meaning is more specific than "Immunosuppressive Agents".
This graph shows the total number of publications written about "Immunosuppressive Agents" by people in this website by year, and whether "Immunosuppressive Agents" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1992 | 5 | 2 | 7 | | 1993 | 4 | 5 | 9 | | 1994 | 1 | 1 | 2 | | 1995 | 10 | 1 | 11 | | 1996 | 25 | 3 | 28 | | 1997 | 9 | 5 | 14 | | 1998 | 7 | 7 | 14 | | 1999 | 11 | 6 | 17 | | 2000 | 12 | 10 | 22 | | 2001 | 17 | 6 | 23 | | 2002 | 11 | 7 | 18 | | 2003 | 13 | 10 | 23 | | 2004 | 15 | 9 | 24 | | 2005 | 16 | 12 | 28 | | 2006 | 9 | 4 | 13 | | 2007 | 10 | 9 | 19 | | 2008 | 13 | 14 | 27 | | 2009 | 16 | 13 | 29 | | 2010 | 19 | 8 | 27 | | 2011 | 13 | 12 | 25 | | 2012 | 10 | 8 | 18 | | 2013 | 22 | 8 | 30 | | 2014 | 19 | 15 | 34 | | 2015 | 16 | 6 | 22 | | 2016 | 10 | 15 | 25 | | 2017 | 16 | 7 | 23 | | 2018 | 10 | 8 | 18 | | 2019 | 10 | 9 | 19 | | 2020 | 15 | 8 | 23 | | 2021 | 5 | 7 | 12 |
To return to the timeline, click here.
Below are the most recent publications written about "Immunosuppressive Agents" by people in Profiles.
-
Trachtman H, Laskowski J, Lee C, Renner B, Feemster A, Parikh S, Panzer SE, Zhong W, Cravedi P, Cantarelli C, Kulik L, You Z, Satchell S, Rovin B, Liu F, Kalled SL, Holers VM, Jalal D, Thurman JM. Natural antibody and complement activation characterize patients with idiopathic nephrotic syndrome. Am J Physiol Renal Physiol. 2021 10 01; 321(4):F505-F516.
-
Kemme S, Feldman AG, Mack C. Severe Seronegative Hepatitis-associated Aplastic Anemia: Looking for the Best Treatment. J Pediatr Gastroenterol Nutr. 2021 08 01; 73(2):e48.
-
Luo J, Beattie JA, Fuentes P, Rizvi H, Egger JV, Kern JA, Leung DYM, Lacouture ME, Kris MG, Gambarin M, Santomasso BD, Faleck DM, Hellmann MD. Beyond Steroids: Immunosuppressants in Steroid-Refractory or Resistant Immune-Related Adverse Events. J Thorac Oncol. 2021 10; 16(10):1759-1764.
-
Burkhard A, Toliver J, Rascati K. Association between multiple sclerosis disease severity and adherence to disease-modifying therapies. J Manag Care Spec Pharm. 2021 Jul; 27(7):915-923.
-
Halabi C, Williams EK, Morshed RA, Caffarelli M, Anastasiou C, Tihan T, Cooke D, Abla AA, Dowd CF, Shah V, Chung S, Richie MB. Neurological manifestations of polyarteritis nodosa: a tour of the neuroaxis by case series. BMC Neurol. 2021 May 21; 21(1):205.
-
Campbell KR, Martins R, Davis S, Juarez-Colunga E. Dynamic prediction based on variability of a longitudinal biomarker. BMC Med Res Methodol. 2021 05 15; 21(1):104.
-
Madduri D, Parekh S, Campbell TB, Neumann F, Petrocca F, Jagannath S. Anti-BCMA CAR T administration in a relapsed and refractory multiple myeloma patient after COVID-19 infection: a case report. J Med Case Rep. 2021 Feb 19; 15(1):90.
-
Riordan M, Oreschak K, Peters LL, Aquilante CL, Ambardekar AV. Bariatric Surgery Is Associated With Decreased Calcineurin Inhibitor Time in Therapeutic Range After Heart Transplantation. Transplant Proc. 2021 Mar; 53(2):681-685.
-
Melaragno JI, Bowman LJ, Park JM, Lourenco LM, Doligalski CT, Brady BL, Descourouez JL, Chandran MM, Nickels MW, Page RL. The Clinical Conundrum of Cannabis: Current Practices and Recommendations for Transplant Clinicians: An Opinion of the Immunology/Transplantation PRN of the American College of Clinical Pharmacy. Transplantation. 2021 02 01; 105(2):291-299.
-
Sabbagh SE, Neely J, Chow A, DeGuzman M, Lai J, Lvovich S, McGrath T, Pereira M, Pinal-Fernandez I, Roberts J, Rouster-Stevens K, Schmeling H, Sura A, Tarshish G, Tucker L, Rider LG, Kim S. Risk factors associated with Pneumocystis jirovecii pneumonia in juvenile myositis in North America. Rheumatology (Oxford). 2021 02 01; 60(2):829-836.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|